Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions

Effective treatment of advanced/metastatic bone and soft tissue sarcomas still represents an unmet medical need. Recent advances in targeted therapies have highlighted the potential of cyclin-dependent kinases (CDK) inhibitors in several cancer types, including sarcomas. CDKs are master regulators o...

Descripción completa

Detalles Bibliográficos
Autores principales: Merlini, Alessandra, Pavese, Valeria, Manessi, Giulia, Rabino, Martina, Tolomeo, Francesco, Aliberti, Sandra, D’Ambrosio, Lorenzo, Grignani, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893281/
https://www.ncbi.nlm.nih.gov/pubmed/36741019
http://dx.doi.org/10.3389/fonc.2023.1095219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893281/
https://www.ncbi.nlm.nih.gov/pubmed/36741019
http://dx.doi.org/10.3389/fonc.2023.1095219

Ejemplares similares